Article
Discovery of Genetic Variants of the Kinases That Activate Tenofovir in a Compartment-specific Manner.
EBioMedicine - 1 Sept 2015
Lade Julie M, To Elaine E, Hendrix Craig W, Bumpus Namandjé N
Abstract excerpt
Tenofovir (TFV) is used in combination with other antiretroviral drugs for human immunodeficiency virus (HIV) treatment and prevention. TFV requires two phosphorylation steps to become pharmacologically active; however, the kinases that activate TFV in cells and tissues susceptible to HIV infection have yet to be identified. Peripheral blood mononuclear cells (PBMC), vaginal, and colorectal tissues were...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
